159 related articles for article (PubMed ID: 2609067)
21. Rational diagnosis and treatment in unclassified arthritis: how clinical data may guide requests for Lyme serology and antibiotic treatment.
Blaauw I; Dijkmans B; Bouma P; van der Linden S
Ann Rheum Dis; 1993 Mar; 52(3):206-10. PubMed ID: 8484673
[TBL] [Abstract][Full Text] [Related]
22. Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis.
Codolo G; Amedei A; Steere AC; Papinutto E; Cappon A; Polenghi A; Benagiano M; Paccani SR; Sambri V; Del Prete G; Baldari CT; Zanotti G; Montecucco C; D'Elios MM; de Bernard M
Arthritis Rheum; 2008 Nov; 58(11):3609-17. PubMed ID: 18975343
[TBL] [Abstract][Full Text] [Related]
23. Lymphoproliferative responses to Borrelia burgdorferi in the diagnosis of Lyme arthritis in children and adolescents.
Huppertz HI; Mösbauer S; Busch DH; Karch H
Eur J Pediatr; 1996 Apr; 155(4):297-302. PubMed ID: 8777923
[TBL] [Abstract][Full Text] [Related]
24. Autoimmune mechanisms in antibiotic treatment-resistant lyme arthritis.
Steere AC; Gross D; Meyer AL; Huber BT
J Autoimmun; 2001 May; 16(3):263-8. PubMed ID: 11334491
[TBL] [Abstract][Full Text] [Related]
25. Borrelia burgdorferi-specific T lymphocytes induce severe destructive Lyme arthritis.
Lim LC; England DM; DuChateau BK; Glowacki NJ; Schell RF
Infect Immun; 1995 Apr; 63(4):1400-8. PubMed ID: 7890402
[TBL] [Abstract][Full Text] [Related]
26. T cell proliferation induced by Borrelia burgdorferi in patients with Lyme borreliosis. Autologous serum required for optimum stimulation.
Krause A; Brade V; Schoerner C; Solbach W; Kalden JR; Burmester GR
Arthritis Rheum; 1991 Apr; 34(4):393-402. PubMed ID: 2012626
[TBL] [Abstract][Full Text] [Related]
27. Proliferative responses of mononuclear cells in Lyme disease. Reactivity to Borrelia burgdorferi antigens is greater in joint fluid than in blood.
Sigal LH; Steere AC; Freeman DH; Dwyer JM
Arthritis Rheum; 1986 Jun; 29(6):761-9. PubMed ID: 2941022
[TBL] [Abstract][Full Text] [Related]
28. Seronegative Lyme arthritis caused by Borrelia garinii.
Dejmková H; Hulínska D; Tegzová D; Pavelka K; Gatterová J; Vavrík P
Clin Rheumatol; 2002 Aug; 21(4):330-4. PubMed ID: 12189466
[TBL] [Abstract][Full Text] [Related]
29. Prominent T lymphocyte response to Borrelia burgdorferi from peripheral blood of unexposed donors.
Roessner K; Fikrig E; Russell JQ; Cooper SM; Flavell RA; Budd RC
Eur J Immunol; 1994 Feb; 24(2):320-4. PubMed ID: 7905415
[TBL] [Abstract][Full Text] [Related]
30. Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis.
Preac-Mursic V; Weber K; Pfister HW; Wilske B; Gross B; Baumann A; Prokop J
Infection; 1989; 17(6):355-9. PubMed ID: 2613324
[TBL] [Abstract][Full Text] [Related]
31. The T-cell proliferative assay in the diagnosis of Lyme disease.
Dressler F; Yoshinari NH; Steere AC
Ann Intern Med; 1991 Oct; 115(7):533-9. PubMed ID: 1883122
[TBL] [Abstract][Full Text] [Related]
32. [The incidence of Lyme arthritis and of antibodies to Borrelia burgdorferi in rheumatology patients in an endemic area].
Lesniak OM; Sokolova ZI; Laĭkovskaia EE; Riabitseva OF
Ter Arkh; 1994; 66(5):45-7. PubMed ID: 7940338
[TBL] [Abstract][Full Text] [Related]
33. Lymphocyte proliferation assay in response to Borrelia burgdorferi in patients with Lyme arthritis: analysis of lymphocyte subsets.
Rutkowski S; Busch DH; Huppertz HI
Rheumatol Int; 1997; 17(4):151-8. PubMed ID: 9440146
[TBL] [Abstract][Full Text] [Related]
34.
Jutras BL; Lochhead RB; Kloos ZA; Biboy J; Strle K; Booth CJ; Govers SK; Gray J; Schumann P; Vollmer W; Bockenstedt LK; Steere AC; Jacobs-Wagner C
Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13498-13507. PubMed ID: 31209025
[TBL] [Abstract][Full Text] [Related]
35. Acrodermatitis chronic atrophicans: a chronic T-cell-mediated immune reaction against Borrelia burgdorferi? Clinical, histologic, and immunohistochemical study of five cases.
Buechner SA; Rufli T; Erb P
J Am Acad Dermatol; 1993 Mar; 28(3):399-405. PubMed ID: 8095272
[TBL] [Abstract][Full Text] [Related]
36. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis.
Nocton JJ; Dressler F; Rutledge BJ; Rys PN; Persing DH; Steere AC
N Engl J Med; 1994 Jan; 330(4):229-34. PubMed ID: 8272083
[TBL] [Abstract][Full Text] [Related]
37. Immunologic aspects of Lyme borreliosis.
Dattwyler RJ; Volkman DJ; Luft BJ
Rev Infect Dis; 1989; 11 Suppl 6():S1494-8. PubMed ID: 2682961
[TBL] [Abstract][Full Text] [Related]
38. Detection of Borrelia burgdorferi by polymerase chain reaction in synovial membrane, but not in synovial fluid from patients with persisting Lyme arthritis after antibiotic therapy.
Priem S; Burmester GR; Kamradt T; Wolbart K; Rittig MG; Krause A
Ann Rheum Dis; 1998 Feb; 57(2):118-21. PubMed ID: 9613343
[TBL] [Abstract][Full Text] [Related]
39. Detection of Borrelia burgdorferi-specific CD8+ cytotoxic T cells in patients with Lyme arthritis.
Busch DH; Jassoy C; Brinckmann U; Girschick H; Huppertz HI
J Immunol; 1996 Oct; 157(8):3534-41. PubMed ID: 8871653
[TBL] [Abstract][Full Text] [Related]
40. Activation of natural killer cells in arthritis-susceptible but not arthritis-resistant mouse strains following Borrelia burgdorferi infection.
Brown CR; Reiner SL
Infect Immun; 1998 Nov; 66(11):5208-14. PubMed ID: 9784524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
